Dysregulated CXCL12 expression in osteoblasts promotes B-lymphocytes preferentially homing to the bone marrow in MRL/lpr mice

References

• Petri M. Systemic lupus erythematosus: 2006 update. J Clin Rheumatol. 2006;12(1):1–11.
   PubMed Web of Science ®Google Scholar
• Chan OT, Madaio MP, Shlomchik MJ. The Central and multiple roles of B cells in lupus pathogenesis. Immunol Rev. 1999;169(1):107–121.
   PubMedGoogle Scholar
• Sayyed SG, Hägele H, Kulkarni OP, et al. Podocytes produce ­homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes. Diabetologia. 2009;52(11):2445–2454.
   PubMed Web of Science ®Google Scholar
• Smith KG, Jones RB, Burns SM, et al. Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: remission, relapse, and re-treatment. Arthritis Rheum. 2006;54(9):2970–2982.
   PubMed Web of Science ®Google Scholar
• Arbitman L, Furie R, Vashistha H. B cell-targeted therapies in systemic lupus erythematosus. J Autoimmun. 2022;132:102873.
   PubMed Web of Science ®Google Scholar
• Wang A, Fairhurst AM, Tus K, et al. CXCR4/CXCL12 hyperexpression plays a pivotal role in the pathogenesis of lupus. J Immunol . 2009;182(7):4448–4458.
   PubMed Web of Science ®Google Scholar
• Chen G, Chen SM, Wang X, et al. Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells. J Biol Chem. 2012;287(15):12132–12141.
   PubMed Web of Science ®Google Scholar
• Yi L, Zhou X, Li T, et al. Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4. J Exp Clin Cancer Res. 2019;38(1):339.
   PubMed Web of Science ®Google Scholar
• Hanaoka H, Okazaki Y, Hashiguchi A, et al. Overexpression of CXCR4 on circulating B cells in patients with active systemic lupus erythematosus. Clin. Exp. Rheumatol. 2015;33:863–870.
   PubMed Web of Science ®Google Scholar
• Barrera-Vargas A, Gómez-Martín D, Carmona-Rivera C, et al. Differential ubiquitination in NETs regulates macrophage responses in systemic lupus erythematosus. Ann Rheum Dis. 2018;77(6):944–950.
   PubMed Web of Science ®Google Scholar
• de la Varga Martínez R, Rodríguez-Bayona B, Añez GA, et al. Clinical relevance of circulating anti-ENA and anti-dsDNA secreting cells from SLE patients and their dependence on STAT-3 activation. Eur J Immunol. 2017;47(7):1211–1219.
   PubMed Web of Science ®Google Scholar
• Balabanian K, Couderc J, Bouchet-Delbos L, et al. Role of the chemokine stromal cell-derived factor 1 in autoantibody production and nephritis in murine lupus. J Immunol. 2003;170(6):170: 3392–3400.
   PubMedGoogle Scholar
• Cheng Q, Khodadadi L, Taddeo A, et al. CXCR4-CXCL12 interaction is important for plasma cell homing and survival in NZB/W mice. Eur J Immunol. 2018;48(6):1020–1029.
   PubMed Web of Science ®Google Scholar
• Power CA. Knock out models to dissect chemokine receptor function in vivo. J Immunol Methods. 2003;273(1–2):73–82.
   PubMed Web of Science ®Google Scholar
• Nagasawa T, Hirota S, Tachibana K, et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature. 1996;382(6592):635–638.
   PubMed Web of Science ®Google Scholar
• Allen CD, Ansel KM, Low C, et al. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat Immunol. 2004;5: (9):943–952.
   PubMed Web of Science ®Google Scholar
• Ma Q, Jones D, Borghesani PR, et al. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci U S A. 1998;95(16):9448–9453.
   PubMed Web of Science ®Google Scholar
• Janssens R, Struyf S, Proost P. Pathological roles of the homeostatic chemokine CXCL12. Cytokine Growth Factor Rev. 2018;44:51–68.
   PubMed Web of Science ®Google Scholar
• Tang Y, Xie H, Chen J, et al. Activated NF-κB in bone marrow mesenchymal stem cells from systemic lupus erythematosus patients inhibits osteogenic differentiation through downregulating smad signaling. Stem Cells Dev. 2013;22(4):668–678.
   PubMed Web of Science ®Google Scholar
• Tang Y, Ma X, Zhang H, et al. Gene expression profile reveals abnormalities of multiple signaling pathways in mesenchymal stem cell derived from patients with systemic lupus erythematosus. Clin Dev Immunol. 2012;2012:826182–826112.
   PubMedGoogle Scholar
• Visnjic D, Kalajzic Z, Rowe DW, et al. Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood. 2004;103(9):3258–3264.
   PubMed Web of Science ®Google Scholar
• Schall N, Daubeuf F, Marsol C, et al. A selective neutraligand for CXCL12/SDF-1α with beneficial regulatory functions in MRL/Lpr lupus prone mice. Front Pharmacol. 2021;12:752194.
   PubMed Web of Science ®Google Scholar
• Semerad CL, Christopher MJ, Liu F, et al. G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood. 2005;106(9):3020–3027.
   PubMed Web of Science ®Google Scholar
• Dörner T, Giesecke C, Lipsky PE. Mechanisms of B cell autoimmunity in SLE. Arthritis Res Ther. 2011;13(5):243.
   PubMed Web of Science ®Google Scholar
• Dörner T, Radbruch A, Burmester GR. B-cell-directed therapies for autoimmune disease. Nat Rev Rheumatol. 2009;5(8):433–441.
   PubMed Web of Science ®Google Scholar
• Malkiel S, Barlev AN, Atisha-Fregoso Y, et al. Plasma cell differentiation pathways in systemic lupus erythematosus. Front Immunol. 2018;9:427.
   PubMed Web of Science ®Google Scholar
• Zhu J, Garrett R, Jung Y, et al. Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem cells. Blood. 2007;109(9):3706–3712.
   PubMed Web of Science ®Google Scholar
• Balakumaran A, Robey PG, Fedarko N, et al. Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosis. Expert Rev Mol Diagn. 2010;10(4):465–480.
   PubMed Web of Science ®Google Scholar
• Crampton SP, Morawski PA, Bolland S. Linking susceptibility genes and pathogenesis mechanisms using mouse models of systemic lupus erythematosus. Dis Model Mech. 2014;7(9):1033–1046.
   PubMed Web of Science ®Google Scholar
• Santiago-Raber ML, Laporte C, Reininger L, et al. Genetic basis of murine lupus. Autoimmun Rev. 2004;3(1):33–39.
   PubMed Web of Science ®Google Scholar
• Kucia M, Jankowski K, Reca R, et al. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol. 2004;35(3):233–245.
   PubMed Web of Science ®Google Scholar
• Devarapu SK, Kumar Vr S, Rupanagudi KV, et al. Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis. Clin Immunol. 2016;169:139–147.
   PubMed Web of Science ®Google Scholar
• Sugiyama T, Kohara H, Noda M, et al. Maintenance of the hematopoietic stem cell Pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity. 2006;25(6):977–988.
   PubMed Web of Science ®Google Scholar
• Sun W, Meednu N, Rosenberg A, et al. B cells inhibit bone formation in rheumatoid arthritis by suppressing osteoblast differentiation. Nat Commun. 2018;9(1):5127.
   PubMedGoogle Scholar
• Espeli M, Bökers S, Giannico G, et al. Local renal autoantibody production in lupus nephritis. J Am Soc Nephrol. 2011;22(2):296–305.
   PubMed Web of Science ®Google Scholar
• Sekine H, Watanabe H, Gilkeson GS. Enrichment of anti-glomerular antigen antibody-producing cells in the kidneys of MRL/MpJ-Fas(lpr) mice. J Immunol . 2004;1950;172(6):3913–3921.
   PubMed Web of Science ®Google Scholar
• Starke C, Frey S, Wellmann U, et al. High frequency of autoantibody-secreting cells and long-lived plasma cells within inflamed kidneys of NZB/W F1 lupus mice. Eur J Immunol. 2011;41(7):2107–2112.
   PubMed Web of Science ®Google Scholar
• Alexander T, Sarfert R, Klotsche J, et al. The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus. Ann Rheum Dis. 2015;74(7):1474–1478.
   PubMed Web of Science ®Google Scholar
• Shachar I, Karin N. The dual roles of inflammatory cytokines and chemokines in the regulation of autoimmune diseases and their clinical implications. J Leukoc Biol. 2013;93(1):51–61.
   PubMed Web of Science ®Google Scholar
• Jacquemin C, Augusto JF, Scherlinger M, et al. OX40L/OX40 axis impairs follicular and natural treg function in human SLE. JCI Insight. 2018;3(24):e122167.
   PubMed Web of Science ®Google Scholar
• Cassese G, Arce S, Hauser AE, et al. Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J Immunol. 2003;171(4):1684–1690.
   PubMed Web of Science ®Google Scholar
• Minges Wols HA, Underhill GH, Kansas GS, et al. The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity. J Immunol. 2002;169(8):4213–4221.
   PubMed Web of Science ®Google Scholar